Allyx Therapeutics
About:
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
Website: https://allyxthera.com
Twitter/X: allyxthera
Top Investors: Bristol-Myers Squibb, Connecticut Innovations, National Institutes of Health, Spring Mountain Capital, Life Science Angels
Description:
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug capable of delivering a disease-modifying approach and preserving cognition in patients.
$13.4M
New Haven, Connecticut, United States
2018-01-01
info(AT)allyxthera.com
Paul Fonteyne, Stephen Bloch, Stephen M. Strittmatter, Timothy Siegert
1-10
2024-10-15
Private
© 2025 bioDAO.ai